Wells Fargo & Company Issues Pessimistic Forecast for Crescent Capital BDC (NASDAQ:CCAP) Stock Price

Crescent Capital BDC (NASDAQ:CCAP) had its target price decreased by Wells Fargo & Company from $19.00 to $18.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective would suggest a potential downside of 2.25% from the stock’s previous close.

Separately, Keefe, Bruyette & Woods raised their price objective on Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a research note on Monday, November 25th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, Crescent Capital BDC has a consensus rating of “Moderate Buy” and an average price target of $19.17.

Crescent Capital BDC Stock Down 3.3 %

Shares of Crescent Capital BDC stock opened at $18.42 on Friday. The firm has a market cap of $682.46 million, a price-to-earnings ratio of 9.25 and a beta of 0.81. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.32 and a quick ratio of 1.26. Crescent Capital BDC has a 52-week low of $16.58 and a 52-week high of $20.19. The stock has a 50-day simple moving average of $19.43 and a 200-day simple moving average of $18.88.

Crescent Capital BDC (NASDAQ:CCAP) last issued its quarterly earnings data on Wednesday, February 19th. The company reported $0.55 earnings per share for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The company had revenue of $46.40 million during the quarter, compared to the consensus estimate of $47.27 million. On average, equities research analysts expect that Crescent Capital BDC will post 2.09 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Montag A & Associates Inc. bought a new position in Crescent Capital BDC in the 4th quarter worth approximately $35,000. C M Bidwell & Associates Ltd. bought a new position in Crescent Capital BDC in the 4th quarter worth approximately $39,000. Aquatic Capital Management LLC bought a new stake in shares of Crescent Capital BDC during the fourth quarter valued at approximately $129,000. Generation Capital Management LLC bought a new stake in shares of Crescent Capital BDC during the fourth quarter valued at approximately $192,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Crescent Capital BDC during the fourth quarter valued at approximately $218,000. 49.46% of the stock is owned by institutional investors.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.